Mr. Sinha received his Bachelors of Science (BS) and Master of Science (MS) degrees in Bacteriology / Natural Science from the University of Wisconsin – Madison, Wisconsin, USA. He completed his Master’s in Business Administration (MBA) from the New York Institute of Technology, New York, USA. Kuntal Sinha has been in the Pharmaceutical industry for over 25 years. His experience over the years have spanned within the Contract Research Organization (CRO) and pharmaceutical companies. At Covance, Mr. Sinha’s responsibility included research supporting Metabolic Chemistry and Drug Metabolism Since 2016, Mr. Sinha has been managing the activities associated with pharmacovigilance and clinical trial safety and serves as an advisory / consultative capacity in compliance related safety matters. More recently, Mr. Sinha is Director at Alkermes within Clinical Quality Assurance group supporting pharmacovigilance, Medical Affairs and Commercial Organization on drug safety related to adverse events and product complaints.